The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of colorectal cancer (CRC), providing an alternative to rival therapy Keytruda ...
EV batteries degrade gradually, not suddenly. Key warning signs include reduced driving range, slower charging, power loss, ...